Navigation Links
New breast cancer drug on the block

A new drug has been approved in Scotland for the treatment of breast cancers in the early stages. The drug named Arimidex seems to be beneficial // specifically in treating breast cancer in women, who have crossed menopause. Arimidex is an aromatase inhibitor that works by inhibiting the oestrogen production in the adrenal gland.

Apparently more than 4,000 women are expected to benefit from the use of this drug. England and Wales also intend to introduce this drug into the market by the end of this year. Keeping in mind the efficacy that has been noted so far, this drug is also due for consideration for the approval by National Institute of Clinical Excellence.

The medical journal Lancet has reported that this drug has helped in halving the risk of the illness relapsing in patients. Lancet Oncology reports that recipients of this drug have shown remarkable improvement after two to three years following surgery, as compared to the standard drug of choice, Tamoxifen. Their chances of succumbing to death on account of the cancer were reduced by 29%.The study reported in Lancet also shows that chances of relapse were minimized by 45% after introduction of this drug. The long term chance of occurrence of any other cancer in the lifetime of the patient also showed a considerable decline of 39% in the studies.

Professor Walter Jonat, the author of the study is confident that this drug will enable the breast cancer patients to face their future with confidence.
MST
'"/>




Page: 1

Related medicine news :

1. Ductal lavage may detect early breast cancer
2. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
3. Micro-camera provides new breast imaging technique
4. Support therapy helps breast cancer patients
5. Variation in breast cancer
6. Appropriate treatment for breast cancer
7. Combination therapy to treat breast cancer
8. Hope for breast cancer patients
9. Pregnancy weight linked to breast cancer
10. New breast cancer genes discovered
11. New breast cancer drug appears encouraging
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... Hotze ... industry, announces Chris Brandl as its New Guest Director. , Brandl is ... corporations throughout his career. He began his professional career at Omnium Worldwide, now ...
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been ... women who become dependent on opioid painkillers has fallen short. From 1999 until 2010, ... a 237% increase in fatal overdoses in male populations.(1) , The proportion of women ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, ... inflammatory gum condition that occurs when the bacteria in plaque infect the gums and ... as a scaling and root planing or SRP, and can include surgical therapies if ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... NEW YORK , February 27, 2017 ... (PII) celebrates the pharmaceutical companies that are most successful at ... ... question: if you gave the same molecule to two different ... it? Based on systematic, objective analysis of each ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies ... grow at a CAGR of 8.9% from 2016-2021 and CAGR of ... CAGR of 9.1% from 2016 to 2027. The market is estimated ... ... Read on to discover how you can exploit the future ...
Breaking Medicine Technology: